Oxford Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Oxford Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,499	Closed	-$1.12M	–	649
2026 Q1	$1.12M	Buy	2,499 +977	+64%	+$456K	0.45%	37
2025 Q4	$690K	Buy	+1,522	New	+$656K	0.24%	134
2025 Q2	–	Sell	-3,202	Closed	-$1.55M	–	780
2025 Q1	$1.55M	Buy	+3,202	New	+$1.49M	0.71%	23
2024 Q4	–	Sell	-689	Closed	-$320K	–	600
2024 Q3	$320K	Buy	+689	New	+$331K	0.27%	151
2024 Q1	–	Sell	-508	Closed	-$207K	–	367
2023 Q4	$207K	Buy	+508	New	+$188K	0.31%	139
2020 Q1	–	Sell	-7,846	Closed	-$1.72M	–	1288
2019 Q4	$1.72M	Buy	+7,846	New	+$1.59M	0.05%	512
2019 Q3	–	Sell	-6,740	Closed	-$1.24M	–	1969
2019 Q2	$1.24M	Sell	6,740 -4,106	-38%	-$718K	0.03%	875
2019 Q1	$2M	Sell	10,846 -23,825	-69%	-$4.4M	0.04%	586
2018 Q4	$5.75M	Buy	+34,671	New	+$6.01M	0.15%	158
2018 Q3	–	Sell	-14,682	Closed	-$2.45M	–	1945
2018 Q2	$2.45M	Sell	14,682 -5,706	-28%	-$884K	0.05%	540
2018 Q1	$3.32M	Buy	+20,388	New	+$3.33M	0.07%	319
2017 Q3	–	Sell	-34,803	Closed	-$4.49M	–	1722
2017 Q2	$4.49M	Buy	34,803 +2,042	+6%	+$246K	0.09%	234
2017 Q1	$3.58M	Buy	+32,761	New	+$2.88M	0.09%	226
2015 Q3	–	Sell	-2,187	Closed	-$270K	–	729
2015 Q2	$270K	Buy	+2,187	New	+$276K	0.01%	577

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Oxford Asset Management's VRTX Position: Q2 2026 in Review

Oxford Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 2,499 shares — an estimated $1.12M sold.

Oxford Asset Management first reported a position in VRTX in Q2 2015 and held it in 14 quarters. The position peaked at $5.75M in Q4 2018. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Oxford Asset Management reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 2,499 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
Oxford Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2015 and held it in 14 quarters.
Oxford Asset Management's Vertex Pharmaceuticals position peaked at $5.75M in Q4 2018.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.